Accelerate to discover

Homepage>Discover>Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Back to filter

Sep 26, 2018

Biomedical researchers are increasingly using advanced human cell models for translational biology and therapeutic...

Sep 3, 2018

Discover the new IncuCyte S3 cell-by-cell analysis software module. The innovative module allow label free analysis to...

Jul 16, 2018

The company producing Avatar, xCELL biosciences have organized a webinar about the tuning of microenvironment to...

Jun 19, 2018

Professor Vande Velde will describe how high-field MRI and low dose microCT complement each other; where microCT gives...

Oct 16, 2018

Jun 5, 2018

Cancer immunotherapies harness and enhance the innate power of the immune system to eliminate cancer cells and have...

May 16, 2018

Watch the new webinar about photoacoustick imaging presented by Dr. Liliya M. Yamaleyeva, Assistant Professor in the...

May 13, 2018

BioFlux biofilm assays can now be performed on the popular catheter material polydimethylsiloxane (PDMS). Silicone...

Oct 16, 2018

Apr 30, 2018

Cancer researchers are increasingly turning to more complex live-cell assay systems that recapitulate key aspects of...

Use of the iQue Screener as a versatile tool for in-vitro immunogenicity and immunotoxicity risk assessment

Sep 29, 2015

Brecht Hoedemaekers, ImmunXperts

November 12th, 4pm BST

REGISTER NOW

Webinar

Get more info

Head of application support

Riccardo

Pasculli

+420 731 127 717

pasculli@accela.eu

Send Message

Brand profile

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.